SCHEMBL8304094

SCHEMBL8304094

NC(OC(=O)/C=C/C(=O)OC(N)C(=O)Nn1cccc1C(=O)c1cccc(F)c1)C(=O)Nn1cccc1C(=O)c1cccc(F)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.35
HDAC6 Q9UBN7 2/20 0.34
CES2 O00748 2/20 0.34
CES1 P23141 2/20 0.34
HDAC1 Q13547 1/20 0.34
POLB P06746 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
HDAC11 Q96DB2 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
PKM P14618 1/20 0.32
PLA2G7 Q13093 1/20 0.32
XPO1 O14980 1/20 0.31
LMNA P02545 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8304732 0.75 PARP1 (0.42) PARP1HDAC6CES2CES1HDAC1
Fumaric Acid SCHEMBL8304091 0.74 KAT6A (0.39) PARP1HDAC6CES2CES1HDAC1
Fumaric Acid SCHEMBL8304095 0.74 KAT6A (0.39) PARP1HDAC6CES2CES1HDAC1
SCHEMBL30733925 0.65 POLB (0.57) PARP1HDAC6CES2CES1HDAC1
SCHEMBL1258944 0.62 CES2 (0.74) PARP1HDAC6CES2CES1HDAC1
SCHEMBL10366987 0.61 ALDH1A1 (0.51) CYP2D6CYP2C9CYP2C19NPC1RAB9A
SCHEMBL2705684 0.60 CES2 (0.71) PARP1HDAC6CES2CES1HDAC1
Hydrochloric Acid SCHEMBL27733562 0.60 CES2 (0.71) PARP1HDAC6CES2CES1HDAC1
Bromide SCHEMBL10374448 0.60 GAA (0.37) CES2CES1POLB
SCHEMBL27004440 0.59 POLB (0.53) HDAC6CES2CES1HDAC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0582182-B1 1-Aminoacetamidopyrroles and 1-amino-2-(substituted) pyrroles and their use for the treatment of neurodegenerative dysfunctions HOECHST MARION ROUSSEL INC (US) 1999-10-20 EP claimed
EP-0582182-B1 1-Aminoacetamidopyrroles and 1-amino-2-(substituted) pyrroles and their use for the treatment of neurodegenerative dysfunctions HOECHST MARION ROUSSEL INC (US) 1999-10-20 EP disclosed
EP-0582182-A1 1-Aminoacetamidopyrroles and 1-amino-2-(substituted) pyrroles and their use for the treatment of neurodegenerative dysfunctions HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1994-02-09 EP disclosed